Used as a key chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of selective enzyme inhibitors and central nervous system modulators. Its fluorinated chroman structure enhances metabolic stability and bioavailability, making it valuable in optimizing drug candidates for improved pharmacokinetics. Commonly employed in asymmetric synthesis routes where the (S)-configuration is critical for biological activity.